• Home
  • Terms of Use
  • Privacy Policy
  • Disclosure
Saturday, June 25, 2022
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Videos
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Videos
No Result
View All Result
Omicron b11529 Variant
No Result
View All Result
Home Omicron Variant

181 Cases Of New Omicron Subvariants – ฺBangkok Post

by NewsReporter
June 24, 2022
in Omicron Variant
Reading Time: 2 mins read
Share on FacebookShare on Twitter

181 cases of new Omicron subvariants

published : 24 Jun 2022 at 16:51

A health official takes a nasal swab for a Covid-19 test in Bangkok’s Sai Mai district. (File photo: Apichit Jinakul)

Thailand has 181 recorded cases of Covid-19’s latest worrisome subvariants, BA.4 and BA.5, which are similar to the Delta variant and therefore potentially harmful to a patient’s lungs, according to the Department of Medical Sciences.

Director-general Supakit Sirilak said on Friday that there had been 181 cases of BA.4 and BA.5 subvariants of the Omicron variant and they posed risks of infection clusters.

The 181 cases were confirmed among 400 samples and consisted of 48 infected arrivals and 133 local cases. Most of them were confirmed in Bangkok, where the most samples were collected for examination, Dr Supakit said.

On Tuesday Ramathibodi Hospital reported that since April the country had registered 49 cases of the two subvariants.

Dr Supakit said the mutation of BA.4 and BA.5 was similar to the Delta variant and posed lung inflammation risks.

He said BA.4 and BA.5 accounted for 45.8% of new Covid-19 cases, BA.2 53.8% and BA.1 the rest.

A person’s antibodies were less effective against BA.4 and BA.5 than they were against other subvariants and some patients with low immunity responded less to medication, the director-general said.

BA.5 should be monitored closely because it was spreading and infections already confirmed in 62 countries, while BA.4 and BA.2 infections were falling. BA.5 was likely to become a dominant strain globally and locally, Dr Supakit said.

The people who had previously contracted other subvariants of Omicron could be infected with BA.4 and BA.5 strains. Those with enough antibodies and booster vaccine shots could better fight off a repeat infection, he said.

Omicron was the world’s only variant of concern as it was the dominant variant, he said.

Dr Supakit acknowledged the government’s decision to further relax Covid-19 controls and said the number of BA.4 and BA.5 cases had not risen significantly. Therefore, it was still unnecessary to intensify control measures, he said.

Do you like the content of this article?

Related Posts

covid-19-disease-severity-in-us-veterans-infected-during-omicron-and-delta-variant-predominant-periods-–-nature.com

COVID-19 Disease Severity In US Veterans Infected During Omicron And Delta Variant Predominant Periods – Nature.com

by NewsReporter
June 25, 2022
0

AbstractThe SARS-CoV-2 Omicron variant is thought to cause less severe disease among the general population, but disease severity among at-risk populations is unknown. We performed a retrospective analysis using a matched cohort of United States veterans to compare the disease severity of subjects infected during Omicron and Delta predominant periods...

covid-19-variant-shot-from-sanofi,-gsk-effective-against-omicron-–-the-wall-street-journal

Covid-19 Variant Shot From Sanofi, GSK Effective Against Omicron – The Wall Street Journal

by NewsReporter
June 25, 2022
0

LONDON—GSK PLC and Sanofi SA reported promising trial results for their Covid-19 vaccine that showed the shot—developed to target the Beta strain of the virus—was particularly effective against the Omicron variant.The two companies said Friday that in a trial involving 13,000 adults, the vaccine demonstrated efficacy of 64.7% against symptomatic...

the-next-covid-booster-shots-will-likely-be-updated-for-omicron-–-edmonton-journal

The Next COVID Booster Shots Will Likely Be Updated For Omicron – Edmonton Journal

by NewsReporter
June 25, 2022
0

Author of the article: A nurse inoculates a man with a booster dose of vaccine against COVID-19 on Feb. 15, 2022. Photo by ALFREDO ESTRELLA / AFP NEW YORK — COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the original...

analysis:-the-next-covid-booster-shots-will-likely-be-updated-for-omicron-–-reuters.com

Analysis: The Next COVID Booster Shots Will Likely Be Updated For Omicron – Reuters.com

by NewsReporter
June 24, 2022
0

REUTERS/Hannah BeierRegister now for FREE unlimited access to Reuters.comNEW YORK (Reuters) - COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the original strain, although some experts suggest they may only offer significant benefits for older and immunocompromised people.Moderna, Pfizer and...

BioMarin’s Hemophilia Gene Therapy Roctavian Wins Conditional EU Backing Amid FDA Delay – FiercePharma

by NewsReporter
June 24, 2022
0

Please enable cookies. We are checking your browser... www.fiercepharma.com Why do I have to complete a CAPTCHA? Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. What can I do to prevent this in the future? If you are on a personal...

Amid M&A Rumors, Merck And Seagen Set To Meet: WSJ – FiercePharma

by NewsReporter
June 24, 2022
0

Why do I have to complete a CAPTCHA? Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. What can I do to prevent this in the future? If you are on a personal connection, like at home, you can run an anti-virus...

Omicron b11529 Variant

© 2021

Navigate Site

  • Home
  • Terms of Use
  • Privacy Policy
  • Disclosure

Follow Us

No Result
View All Result
  • Home

© 2021